Nanexa selects the substance for the NEX-18 product project
News
Uppsala 11th December 2018
Nanexa selects the substance for the NEX-18 product project
Nanexa has begun the preclinical development of NEX-18 and has now conducted a technical evaluation of 5-azacitidine in the company’s PharmaShell® process.
Nanexa is awarded a Vinnova grant for the NEX-18 product project
News
Uppsala 26th November 2018
Nanexa is awarded a Vinnova grant for the NEX-18 product project
Nanexa has received a grant of 500,000 SEK for the product project NEX-18 * from Sweden’s innovation agency Vinnova through the announcement “Runner up SME Instrument 2018”.
